SCHEMBL22022220

SCHEMBL22022220

CC(C)CCN(C)C(=O)CCOCCOCCOCCOCCOCCC(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22454227 1.00 — —
SCHEMBL26493934 1.00 — —
SCHEMBL26493918 0.89 — —
SCHEMBL22166537 0.87 TDP1 (0.32) —
SCHEMBL22021657 0.86 — —
SCHEMBL22021682 0.86 — —
SCHEMBL22166528 0.86 — —
SCHEMBL22564686 0.86 TDP1 (0.35) —
SCHEMBL22021684 0.86 — —
SCHEMBL22022270 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200157078-A1 NOVEL COMPOUNDS HAVING ESTROGEN RECEPTOR ALPHA DEGRADATION ACTIVITY AND USES THEREOF ACCUTAR BIOTECHNOLOGY INC. (US) 2020-05-21 — — US disclosed
Send feedback